In addition to other MM indications, Isatuximab's anti-CD38 competitor on the US market, daratumumab (Darzalex — Johnson & Johnson), also carries a first-line indication for transplant-ineligible MM ...

This latest FDA decision marks the first approval for SNY's Sarclisa as a first-line treatment for multiple myeloma patients.

The 21st annual meeting of the International Myeloma Society takes place September 25-28, 2024, in Rio de Janiero, Brazil.

Approval based on positive results from the IMROZ phase 3 study demonstrating Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) significantly improved progression-free ...

The US Food and Drug Administration (FDA) has approved Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) as a first line treatment option for adult patients ...

And the agency expanded the approval of bimekizumab (Bimzelx) to include psoriatic arthritis, non-radiographic axial spondyloarthritis, and ankylosing spondylitis, UCB Announced.

The FDA has approved Sarclisa (isatuximab) as a first-line therapy for blood cancer multiple myeloma as a combination regimen ...

The FDA approved Sanofi's Sarclisa (isatuximab) in combination with VRd as a first-line treatment for newly diagnosed ...

Pakistan PM Shehbaz to raise Kashmir, Palestine, Islamophobia issues at UNGA Pakistan Prime Minister Shehbaz Sharif is set to address the United Nations General Assembly on September 27. He will ...

Ryan Routh, aged 58, allegedly attempted to assassinate former President Donald Trump at his Florida golf course by aiming a rifle through the tree line. He had earlier written a letter offering $ ...

Trump and the Republican National Committee he controls decided to share get-out-the-vote duties in the most competitive states with groups such as the one supported by billionaire Elon Musk.

The iPhone 16 Pro's High-Res Slow Motion Video Is the Best Apple Feature in Years ...